These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Acetylcholine receptor antibody-mediated animal models of myasthenia gravis and the role of complement. Kusner LL; Sengupta M; Kaminski HJ Ann N Y Acad Sci; 2018 Feb; 1413(1):136-142. PubMed ID: 29356015 [TBL] [Abstract][Full Text] [Related]
10. The role of acetylcholine receptor antibodies in myasthenia gravis. Appel SH; Elias SB; Chauvin P Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014 [TBL] [Abstract][Full Text] [Related]
11. A form of acute experimental autoimmune myasthenia gravis in mice occurring in absence of detectable circulating anti-acetylcholine receptor antibodies. Acute experimental myasthenia in mice. Granato D; Piguet PF; Fulpius BW J Neurol Sci; 1980 Sep; 47(3):379-83. PubMed ID: 7420113 [TBL] [Abstract][Full Text] [Related]
12. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis. Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656 [TBL] [Abstract][Full Text] [Related]
13. Immunological similarities between an experimental autoimmune myasthenia gravis model and human myasthenia gravis. Souan ML; Geffard M Neurosci Lett; 1986 Aug; 68(3):282-7. PubMed ID: 2427976 [TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis and pathophysiology of myasthenia gravis--the role of thymus in myasthenia gravis (author's transl)]. Ohshima F No To Shinkei; 1980 Sep; 32(9):909-19. PubMed ID: 7437164 [No Abstract] [Full Text] [Related]
15. Purification of high-affinity Fab fragments from experimental autoimmune myasthenia gravis rabbits and their effect on isolated acetylcholine receptors. Mihovilovic M; Martinez-Carrion M Biochemistry; 1979 Oct; 18(21):4522-8. PubMed ID: 497153 [No Abstract] [Full Text] [Related]
16. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor. Barchan D; Asher O; Tzartos SJ; Fuchs S; Souroujon MC Eur J Immunol; 1998 Feb; 28(2):616-24. PubMed ID: 9521072 [TBL] [Abstract][Full Text] [Related]
17. The pathogenesis of myasthenia gravis. Fulpius BW Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):25-31. PubMed ID: 667413 [TBL] [Abstract][Full Text] [Related]
18. Effect of anti-idiotopic antibody on the course of experimental autoimmune myasthenia gravis. Agius MA; Yuen E Ann N Y Acad Sci; 1998 May; 841():584-6. PubMed ID: 9668301 [No Abstract] [Full Text] [Related]
20. Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune response. Wauben MH; Hoedemaekers AC; Graus YM; Wagenaar JP; van Eden W; de Baets MH Eur J Immunol; 1996 Dec; 26(12):2866-75. PubMed ID: 8977279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]